Trademark: 79063980
Word
HYBRIGENICS
Status Date
Thursday, January 30, 2020
Registration Number
3731611
Registration Date
Tuesday, December 29, 2009
Filing Date
Friday, March 7, 2008
Published for Opposition
Tuesday, October 13, 2009
9 [ Computer programs, software and software packages, all for the scientific analysis and research used in biology, bio-computing, biochemistry, biotechnology, pharmaceuticals, proteomics, genomics, the cosmetics industry and agronomy; interface boards for computers, apparatus for recording, transmission and reproduction of sound; data processing and computer equipment in the nature of data processors and computers, all the aforesaid goods being used in biology, bio-computing, biochemistry, biotechnology, pharmaceuticals, proteomics, genomics, the cosmetics industry and agronomy ]
5 [ Pharmaceuticals, namely, pharmaceutical preparations for the prevention and treatment of disorders of the immune system, the cardiovascular system, the metabolic system, genito-urinary system, the musculo-skeletal system, dermatologic system, alimentary tract, sensory organs, and parasitic diseases, for the treatment of inflammatory disorders for use in dermatology, oncology, hematology and in tissue and organ transplantation and for gastrointestinal disorders; chemico-pharmaceutical preparations, namely, for use in treatment of viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; pharmaceutical products used in the treatment of viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; antibiotics, biological, biochemical and biotechnological preparations for medical purposes, chemical preparations for pharmaceutical purposes for the treatment of neurological, inflammatory, immunological, dermatological, viral, and infectious diseases, infections, parasites, cancer, neurodegenerative diseases, obesity, and diabetes; reagents in the nature of cultures of microorganisms for medical use; surgical tissues, namely, surgical implants comprising living tissue ]
38 [ Telecommunications, namely, transmission of information via computer transmission, digital networks, electronic communications networks; and the telecommunication networks; communications by computer terminals and by means of telecommunications in the nature of communication via analogue and digital computer terminals and by satellite; transmission of information, namely, via computer networks; communications and exchange of information on a telecommunications network; computer-assisted transmission of images, data, and messages; providing multiple use access to global computer information networks for data dissemination over a telecommunications network; provision of access to databases by means of computer servers; communication by hypertext links over a telecommunications network and particularly, the Internet; providing e-mail services; data transmission services, namely, the transmission of data into electronic directories and information transmission via telecommunications networks, all the aforesaid services being used in biology, bio-computing, biochemistry, biotechnology, pharmaceuticals, proteomics, genomics, the cosmetics industry and agronomy; information exchange services over a telecommunication network, namely, information in the field of telecommunications, radio, telegraphic, telephone, and telematic communications, broadcasting of information by the way of a database on the Internet in the pharmaceutical field; rental of access time to a database server; rental of access time to a computer for the handling of data, all these services being used in biology, bioinformatics, biochemistry, biotechnology, pharmaceuticals, proteomics, genomics, the cosmetics industry and agronomy ]
35 [ Subscription services to databases in the nature of subscription to electronic journals; database management, namely, provision of computer databases; all the aforesaid services being used in biology, bio-computing, biochemistry, biotechnology, pharmaceuticals, proteomics, genomics, the cosmetics industry and agronomy ]
1 [ Biological materials, namely, biological reagents commonly known as probes for detecting and analyzing molecules in protein or nucleotide arrays for scientific or medical research; proteins intended for producing protein for therapeutic use, namely, protein arrays for scientific and medical research and therapeutic proteins for scientific use in drug discovery ]
42 Scientific and industrial research; [ the refinement of industrial processes and automation, namely, updates of industrial process control; ] professional consultancy in the fields of industrial and scientific research, namely, in biology, bio-computing, biochemistry, biotechnology, pharmaceuticals, proteomics, genomics, the cosmetics industry and agronomy, [ materials testing, ] laboratories in the nature of chemical, biological and medical laboratories, computer programming, all the aforesaid services being used in biology, bio-computing, biochemistry, biotechnology, pharmaceuticals, proteomics, genomics, the cosmetics industry and agronomy; industrial and scientific research in the field of molecular biology, namely, in genomics, proteomics, protein screening and research of protein interactions
The mark consists of the wording "HYBRIGENCIS" in stylized font.
Color is not claimed as a feature of the mark.
Jan 30, 2009
New Application Office Supplied Data Entered
Jan 29, 2009
Sn Assigned For Sect 66a Appl From Ib
Aug 10, 2009
Teas Response To Office Action Received
Jan 30, 2009
Assigned To Examiner
Feb 3, 2009
Application Filing Receipt Mailed
Feb 10, 2009
Non-Final Action Written
Feb 11, 2009
Non-Final Action (Ib Refusal) Prepared For Review
Feb 11, 2009
Refusal Processed By Mpu
Feb 11, 2009
Non-Final Action Mailed - Refusal Sent To Ib
Mar 6, 2009
Refusal Processed By Ib
Jul 10, 2009
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 10, 2009
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 26, 2010
Final Disposition Processed
Aug 25, 2009
Assigned To Lie
Aug 25, 2009
Correspondence Received In Law Office
Aug 25, 2009
Teas/Email Correspondence Entered
Sep 8, 2009
Approved For Pub - Principal Register
Sep 10, 2009
Law Office Publication Review Completed
Oct 13, 2009
Published For Opposition
Oct 13, 2009
Official Gazette Publication Confirmation E-Mailed
Dec 29, 2009
Registered-Principal Register
Mar 29, 2010
Final Disposition Notice Created, To Be Sent To Ib
Jan 28, 2016
Registered - Partial Sec 71 Accepted
Apr 26, 2010
Final Disposition Notice Sent To Ib
May 18, 2013
Final Decision Transaction Processed By Ib
Nov 18, 2015
Teas Section 71 Received
Dec 30, 2015
Case Assigned To Post Registration Paralegal
Dec 31, 2015
Post Registration Action Mailed - Sec.71
Jan 21, 2016
Registered - Partial Sec 71 Accepted
Jan 21, 2016
Registered - Partial Sec 71 Accepted
Jan 21, 2016
Notice Of Acceptance Of Sec. 71 - Mailed
Jan 21, 2016
Notice Of Acceptance Of Sec. 71 - E-Mailed
Jan 28, 2016
Registered - Partial Sec 71 Accepted
Dec 11, 2019
Teas Section 71 Received
Jan 28, 2016
Notice Of Acceptance Of Sec. 71 - Mailed
Jan 28, 2016
Notice Of Acceptance Of Sec. 71 - E-Mailed
Sep 28, 2016
Partial Invalidation Of Reg Ext Protection Created
Mar 4, 2017
Generic Madrid Transaction Created
Mar 4, 2017
Generic Madrid Transaction Sent To Ib
Jun 23, 2017
Partial Invalidation Processed By The Ib
Apr 5, 2018
International Registration Renewed
Dec 29, 2018
Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed
Jan 29, 2020
Case Assigned To Post Registration Paralegal
Jan 30, 2020
Registered - Partial Sec 71 Accepted
Jan 30, 2020
Notice Of Acceptance Of Sec. 71 - E-Mailed
Nov 13, 2020
Partial Invalidation Processed By The Ib
Sep 30, 2020
Partial Invalidation Of Reg Ext Protection Created
Oct 21, 2020
Invalidation Processed
Oct 21, 2020
Partial Invalidation Of Reg Ext Protection Sent To Ib
Trademark Alertz updated from USPTO on 2030-01-24
